How human tumor viruses make use of autophagy

Cells

Volumn 1, Issue 3, 2012, Pages 617-630

  Pratt, Zachary L ^a   Sugden, Bill ^b  

^a UNIVERSITY OF WISCONSIN   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Autophagy; Cancer; Epstein Barr Virus; Hepatitis B Virus; Hepatitis C Virus; Human tumor virus; Kaposi's Sarcoma Herpesvirus

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN 1; FLICE INHIBITORY PROTEIN; LATENT MEMBRANE PROTEIN 1; PROTEIN BCL 2; VIRUS PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; AUTOPHAGY; EPSTEIN BARR VIRUS; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN HERPESVIRUS 8; LIFE CYCLE; LIVER CELL CARCINOMA; LYMPHOMA; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIMARY EFFUSION LYMPHOMA; TUMOR VIRUS; UNFOLDED PROTEIN RESPONSE; VIRUS INFECTION;

EID: 84909989028     PISSN: None     EISSN: 20734409     Source Type: Journal    
DOI: 10.3390/cells1030617     Document Type: Article

References (59)

1. Kroemer, G.; Marino, G.; Levine, B. Autophagy and the integrated stress response. Mol. Cell 2010, 40, 280-293.
2. He, C.; Klionsky, D.J. Regulation mechanisms and signaling pathways of autophagy. Annu. Rev. Genet. 2009, 43, 67-93.
3. He, C.; Bassik, M.C.; Moresi, V.; Sun, K.; Wei, Y.; Zou, Z.; An, Z.; Loh, J.; Fisher, J.; Sun, Q.; et al. Exercise-induced BCL2-regulated autophagy is required for muscle glucose homeostasis. Nature 2012, 481, 511-515.
4. Yang, Z.; Klionsky, D.J. Mammalian autophagy: Core molecular machinery and signaling regulation. Curr. Opin. Cell Biol. 2010, 22, 124-131.
5. Long, H.M.; Haigh, T.A.; Gudgeon, N.H.; Leen, A.M.; Tsang, C.W.; Brooks, J.; Landais, E.; Houssaint, E.; Lee, S.P.; Rickinson, A.B.; et al. CD4+ T-Cell responses to Epstein-Barr Virus (EBV) latent-cycle antigens and the recognition of EBV-transformed lymphoblastoid cell lines. J. Virol. 2005, 79, 4896-4907.
6. Leung, C.S.; Haigh, T.A.; Mackay, L.K.; Rickinson, A.B.; Taylor, G.S. Nuclear location of an endogenously expressed antigen, EBNA1, restricts access to macroautophagy and the range of CD4 Epitope display. Proc. Natl. Acad. Sci. USA 2010, 107, 2165-2170.
7. Dirmeier, U.; Hoffmann, R.; Kilger, E.; Schultheiss, U.; Briseno, C.; Gires, O.; Kieser, A.; Eick, D.; Sugden, B.; Hammerschmidt, W. Latent Membrane Protein 1 of Epstein-Barr Virus coordinately regulates proliferation with control of apoptosis. Oncogene 2005, 24, 1711-1717.
8. Lee, J.; Sugden, B. A membrane leucine heptad contributes to trafficking, signaling, and transformation by Latent Membrane Protein 1. J. Virol. 2007, 81, 9121-9130.
9. Kaykas, A.; Sugden, B. The amino-terminus and membrane-spanning domains of LMP-1 inhibit cell proliferation. Oncogene 2000, 19, 1400-1410.
10. Lee, D.Y.; Lee, J.; Sugden, B. The unfolded protein response and autophagy: Herpesviruses rule! J. Virol. 2009, 83, 1168-1172.
11. Young, A.R.; Narita, M.; Ferreira, M.; Kirschner, K.; Sadaie, M.; Darot, J.F.; Tavare, S.; Arakawa, S.; Shimizu, S.; Watt, F.M.; et al. Autophagy mediates the mitotic senescence transition. Genes Dev. 2009, 23, 798-803.
12. Sinha, S.; Colbert, C.L.; Becker, N.; Wei, Y.; Levine, B. Molecular basis of the regulation of Beclin 1-Dependent autophagy by the Gamma-Herpesvirus 68 Bcl-2 homolog M11. Autophagy 2008, 4, 989-997.
13. Kabeya, Y.; Mizushima, N.; Yamamoto, A.; Oshitani-Okamoto, S.; Ohsumi, Y.; Yoshimori, T. LC3, GABARAP and GATE16 localize to autophagosomal membrane depending on form-II formation. J. Cell Sci. 2004, 117, 2805-2812.
14. Gregoire, I.P.; Richetta, C.; Meyniel-Schicklin, L.; Borel, S.; Pradezynski, F.; Diaz, O.; Deloire, A.; Azocar, O.; Baguet, J.; Le Breton, M.; et al. IRGM is a common target of RNA viruses that subvert the autophagy network. PLoS Pathog. 2011, 7, e1002422.
15. Dar, W.A.; Sugden, B. Epstein-Barr Virus as a Pathogen. In Viral Oncology: Basic Science and Clinical Applications; Khalili, K., Jeang, K.T., Eds.; John Wiley & Sons, Inc.: Hoboken, NJ, USA, 2010; pp. 425-451.
16. Babcock, G.J.; Decker, L.L.; Volk, M.; Thorley-Lawson, D.A. EBV persistence in memory B cells in vivo. Immunity 1998, 9, 395-404.
17. Nanbo, A.; Sugden, A.; Sugden, B. The Coupling of Synthesis and partitioning of EBV's plasmid replicon is revealed in live cells. EMBO J. 2007, 26, 4252-4262.
18. Vereide, D.; Sugden, B. Proof for EBV's sustaining role in Burkitt's lymphomas. Semin. Cancer Biol. 2009, 19, 389-393.
19. Vereide, D.; Sugden, B. Lymphomas depend on EBV in proportion to their expression of viral genes. Blood 2011, 117, 1977-1985.
20. Levitskaya, J.; Coram, M.; Levitsky, V.; Imreh, S.; Steigerwald-Mullen, P.M.; Klein, G.; Kurilla, M.G.; Masucci, M.G. Inhibition of antigen processing by the internal repeat region of the Epstein-Barr Virus nuclear Antigen-1. Nature 1995, 375, 685-688.
21. Leen, A.; Meij, P.; Redchenko, I.; Middeldorp, J.; Bloemena, E.; Rickinson, A.; Blake, N. Differential immunogenicity of Epstein-Barr Virus latent-cycle proteins for human CD4(+) T-Helper 1 responses. J. Virol. 2001, 75, 8649-8659.
22. Munz, C.; Bickham, K.L.; Subklewe, M.; Tsang, M.L.; Chahroudi, A.; Kurilla, M.G.; Zhang, D.; O'Donnell, M.; Steinman, R.M. Human CD4(+) T lymphocytes consistently respond to the latent Epstein-Barr Virus nuclear Antigen EBNA1. J. Exp. Med. 2000, 191, 1649-1660.
23. Paludan, C.; Schmid, D.; Landthaler, M.; Vockerodt, M.; Kube, D.; Tuschl, T.; Munz, C. Endogenous MHC class II processing of a viral nuclear antigen after autophagy. Science 2005, 307, 593-596.
24. Nimmerjahn, F.; Milosevic, S.; Behrends, U.; Jaffee, E.M.; Pardoll, D.M.; Bornkamm, G.W.; Mautner, J. Major histocompatibility complex class II-restricted presentation of a cytosolic antigen by autophagy. Eur. J. Immunol. 2003, 33, 1250-1259.
25. Mautner, J.; Pich, D.; Nimmerjahn, F.; Milosevic, S.; Adhikary, D.; Christoph, H.; Witter, K.; Bornkamm, G.W.; Hammerschmidt, W.; Behrends, U. Epstein-Barr Virus nuclear Antigen 1 evades direct immune recognition by CD4+ T helper cells. Eur. J. Immunol. 2004, 34, 2500-2509.
26. Paludan, C.; Bickham, K.; Nikiforow, S.; Tsang, M.L.; Goodman, K.; Hanekom, W.A.; Fonteneau, J.F.; Stevanovic, S.; Munz, C. Epstein-Barr nuclear Antigen 1-Specific CD4(+) Th1 cells kill Burkitt's lymphoma cells. J. Immunol. 2002, 169, 1593-1603.
27. Altmann, M.; Hammerschmidt, W. Epstein-Barr Virus provides a new paradigm: A requirement for the immediate inhibition of apoptosis. PLoS Biol. 2005, 3, e404.
28. Kelly, G.L.; Long, H.M.; Stylianou, J.; Thomas, W.A.; Leese, A.; Bell, A.I.; Bornkamm, G.W.; Mautner, J.; Rickinson, A.B.; Rowe, M. An Epstein-Barr Virus anti-apoptotic protein constitutively expressed in transformed cells and implicated in burkitt lymphomagenesis: The Wp/BHRF1 link. PLoS Pathog. 2009, 5, e1000341.
29. Pattingre, S.; Tassa, A.; Qu, X.; Garuti, R.; Liang, X.H.; Mizushima, N.; Packer, M.; Schneider, M.D.; Levine, B. Bcl-2 antiapoptotic proteins inhibit beclin 1-Dependent autophagy. Cell 2005, 122, 927-939.
30. Graham, J.P.; Arcipowski, K.M.; Bishop, G.A. Differential B-Lymphocyte regulation by CD40 and its viral mimic, Latent Membrane Protein 1. Immunol. Rev. 2010, 237, 226-248.
31. Zimber-Strobl, U.; Kempkes, B.; Marschall, G.; Zeidler, R.; van Kooten, C.; Banchereau, J.; Bornkamm, G.W.; Hammerschmidt, W. Epstein-Barr Virus Latent Membrane Protein (LMP1) is not sufficient to maintain proliferation of B cells but both it and activated CD40 can prolong their survival. EMBO J. 1996, 15, 7070-7078.
32. Rastelli, J.; Homig-Holzel, C.; Seagal, J.; Muller, W.; Hermann, A.C.; Rajewsky, K.; Zimber-Strobl, U. LMP1 signaling can replace CD40 signaling in B cells in vivo and has unique features of inducing class-switch recombination to IgG1. Blood 2008, 111, 1448-1455.
33. Sammond, D.W.; Joce, C.; Takeshita, R.; McQuate, S.E.; Ghosh, N.; Martin, J.M.; Yin, H. Transmembrane peptides used to investigate the homo-oligomeric interface and binding hotspot of Latent Membrane Protein 1. Biopolymers 2011, 95, 772-784.
34. Lee, D.Y.; Sugden, B. The Latent Membrane Protein 1 oncogene modifies B-Cell physiology by regulating autophagy. Oncogene 2008, 27, 2833-2842.
35. Lee, D.Y.; Sugden, B. The LMP1 oncogene of EBV activates PERK and the unfolded protein response to drive its own synthesis. Blood 2008, 111, 2280-2289.
36. Lam, N.; Sandberg, M.L.; Sugden, B. High physiological levels of LMP1 result in phosphorylation of eIF2 Alpha in Epstein-Barr Virus-infected cells. J. Virol. 2004, 78, 1657-1664.
37. Liang, C.Y.; Jung, J.U. Downregulation of autophagy by herpesvirus Bcl-2 homologs. Autophagy 2008, 4, 268-272.
38. Sun, R.; Lin, S.F.; Gradoville, L.; Yuan, Y.; Zhu, F.; Miller, G. A viral gene that activates lytic cycle expression of Kaposi's Sarcoma-associated herpesvirus. Proc. Natl. Acad. Sci. USA 1998, 95, 10866-10871.
39. Su, W.C.; Chao, T.C.; Huang, Y.L.; Weng, S.C.; Jeng, K.S.; Lai, M.M. Rab5 and class III phosphoinositide 3-Kinase Vps34 are involved in Hepatitis C Virus NS4B-induced autophagy. J. Virol. 2011, 85, 10561-10571.
40. Wen, H.J.; Yang, Z.; Zhou, Y.; Wood, C. Enhancement of autophagy during lytic replication by the Kaposi's Sarcoma-associated herpesvirus replication and transcription activator. J. Virol. 2010, 84, 7448-7458.
41. Saito, T.; Owen, D.M.; Jiang, F.; Marcotrigiano, J.; Gale, M., Jr. Innate immunity induced by composition-dependent RIG-I recognition of Hepatitis C Virus RNA. Nature 2008, 454, 523-527.
42. Rouschop, K.M.; van den Beucken, T.; Dubois, L.; Niessen, H.; Bussink, J.; Savelkouls, K.; Keulers, T.; Mujcic, H.; Landuyt, W.; Voncken, J.W.; et al. The unfolded protein response protects human tumor cells during hypoxia through regulation of the autophagy genes MAP1LC3B and ATG5. J. Clin. Invest. 2010, 120, 127-141.
43. Martin, J.N. The Epidemiology of KSHV and its Association with Malignant Disease. In Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis; Arvin, A., Campadelli-Fiume, G., Mocarski, E., Moore, P.S., Roizman, B., Whitley, R., Yamanishi, K., Eds.: Cambridge University Press: Cambridge, UK, 2007.
44. Lee, J.S.; Li, Q.; Lee, J.Y.; Lee, S.H.; Jeong, J.H.; Lee, H.R.; Chang, H.; Zhou, F.C.; Gao, S.J.; Liang, C.; et al. FLIP-mediated autophagy regulation in cell death control. Nat. Cell Biol. 2009, 11, 1355-1362.
45. Leidal, A.M.; Cyr, D.P.; Hill, R.J.; Lee, P.W.; McCormick, C. Subversion of autophagy by kaposi's sarcoma-associated herpesvirus impairs oncogene-induced senescence. Cell. Host Microbe 2012, 11, 167-180.
46. Chang, N.C.; Nguyen, M.; Germain, M.; Shore, G.C. Antagonism of Beclin 1-dependent autophagy by BCL-2 at the endoplasmic reticulum requires NAF-1. EMBO J. 2010, 29, 606-618.
47. Guito, J.; Lukac, D.M. KSHV Rta promoter specification and viral reactivation. Front. Microbiol. 2012, 3, 30.
48. Dreux, M.; Gastaminza, P.; Wieland, S.F.; Chisari, F.V. The autophagy machinery is required to initiate Hepatitis C virus replication. Proc. Natl. Acad. Sci. USA 2009, 106, 14046-14051.
49. Ke, P.Y.; Chen, S.S. Activation of the unfolded protein response and autophagy after Hepatitis C virus infection suppresses innate antiviral immunity in vitro. J. Clin. Invest. 2011, 121, 37-56.
50. Guevin, C.; Manna, D.; Belanger, C.; Konan, K.V.; Mak, P.; Labonte, P. Autophagy protein ATG5 interacts transiently with the Hepatitis C Virus RNA Polymerase (NS5B) early during infection. Virology 2010, 405, 1-7.
51. Fujita, N.; Itoh, T.; Omori, H.; Fukuda, M.; Noda, T.; Yoshimori, T. The Atg16L complex specifies the site of LC3 lipidation for membrane biogenesis in autophagy. Mol. Biol. Cell 2008, 19, 2092-2100.
52. Li, X.D.; Chiu, Y.H.; Ismail, A.S.; Behrendt, C.L.; Wight-Carter, M.; Hooper, L.V.; Chen, Z.J. Mitochondrial antiviral signaling protein (MAVS) monitors commensal bacteria and induces an immune response that prevents experimental colitis. Proc. Natl. Acad. Sci. USA 2011, 108, 17390-17395.
53. Taguwa, S.; Kambara, H.; Fujita, N.; Noda, T.; Yoshimori, T.; Koike, K.; Moriishi, K.; Matsuura, Y. Dysfunction of autophagy participates in vacuole formation and cell death in cells replicating Hepatitis C Virus. J. Virol. 2011, 85, 13185-13194.
54. Schadler, S.; Hildt, E. HBV life cycle: Entry and morphogenesis. Viruses 2009, 1, 185-209.
55. Sir, D.; Tian, Y.; Chen, W.L.; Ann, D.K.; Yen, T.S.; Ou, J.H. The early autophagic pathway is activated by Hepatitis B Virus and required for viral DNA replication. Proc. Natl. Acad. Sci. USA 2010, 107, 4383-4388.
56. Tian, Y.; Sir, D.; Kuo, C.F.; Ann, D.K.; Ou, J.H. Autophagy required for Hepatitis B Virus replication in transgenic mice. J. Virol. 2011, 85, 13453-13456.
57. Li, J.; Liu, Y.; Wang, Z.; Liu, K.; Wang, Y.; Liu, J.; Ding, H.; Yuan, Z. Subversion of cellular autophagy machinery by Hepatitis B Virus for viral envelopment. J. Virol. 2011, 85, 6319-6333.
58. Doyle, K.M.; Kennedy, D.; Gorman, A.M.; Gupta, S.; Healy, S.J.; Samali, A. Unfolded proteins and endoplasmic reticulum stress in neurodegenerative disorders. J. Cell. Mol. Med. 2011, 15, 2025-2039.
59. Dreux, M.; Chisari, F.V. Impact of the autophagy machinery on Hepatitis C Virus infection. Viruses 2011, 3, 1342-1357.